Brind.

The FDA reviews a voluntary recall of a blood pressure drug.

Steady: 1 in the last 7 days Updated tuesday

The latest in this situation

  1. FDA found Chlorthalidone failed quality standards, initiating a recall review process.

How it started

2 reports, 2 independent, last reported Mon 00:00. The briefing below covers this first event.

AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 2 outlets

The FDA reviews a voluntary recall of a blood pressure drug.

Who's involved

What this event is mainly about
FDA

How it developed

Newest first. Tap a step to see who reported it.
  1. FDA found Chlorthalidone failed quality standards, initiating a recall review process.1 source
  2. Amgen initiated a voluntary recall of lots of heart and kidney medication.Sub-event
  3. FDA is reviewing a voluntary recall of a blood pressure drug.1 source

Keep exploring

The entities involved

Related events

Coverage

Newest first; wire copies grouped